Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial
Luciano Gattinoni(Universitätsmedizin Göttingen), P. Christian Schulze(Temple College), Ingmar Lautenschlaeger(University Hospital Schleswig-Holstein), Sirak Petros(Universitätsmedizin Greifswald), Alexander Zarbock(University Hospital Münster), Falk Fichtner(University Hospital Leipzig), Josef Briegel(LMU Klinikum), Stefan Kluge(Universität Hamburg), Stefan Utzolino(University Medical Center Freiburg), Barbara Kapfer(TUM Klinikum), Axel Nierhaus(Universität Hamburg), Christian Putensen(University Hospital Bonn), Ivan Tanev(University Hospital Magdeburg), Frank M. Brunkhorst, Yasser Sakr(The University of Texas MD Anderson Cancer Center), Michael Bauer(Jena University Hospital), Christian Scheer(Universitätsmedizin Greifswald), Onnen Moerer(Universitätsmedizin Göttingen), Michael Quintel(Universitätsmedizin Göttingen), David Jacob(University Hospital Schleswig-Holstein), Ulricke Schumacher(University Hospital Bonn), Norbert Weiler, Petra Bischoff(FZI Research Center for Information Technology), Ulrich Jaschinski(University Hospital Augsburg), Katja E. Wartenberg(Leipzig University of Applied Sciences), Fritz Fiedler(TUM Klinikum)
Cited by 34
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Sepsis in European intensive care units: Results of the SOAP study*
|Critical Care Medicine|2006|2.9k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k